Fake Weight-Loss Drugs Pose Serious Health Risks

A significant seizure of counterfeit tirzepatide injections, valued at Rs 56 lakh, has been made in Gurugram, exposing an illicit operation distributing these weight-loss drugs. Medical professionals are increasingly concerned about the availability of fake medications. Diabetologist Anoop Misra reported instances where patients experienced less weight loss than expected, prompting fears of counterfeit supplies. These fake drugs pose substantial health risks.

Identifying counterfeit versions of tirzepatide is exceptionally difficult, as they often appear identical to genuine products. Experts warn that these fake injections may contain no active ingredients or harmful contaminants. Moreover, improper storage can degrade the potency of genuine drugs, making them ineffective. Patients injecting these substances may experience inadequate weight loss or dangerous adverse effects.

The circulation of counterfeit or degraded tirzepatide can lead to uncontrolled obesity-related conditions like diabetes and hypertension. It can also cause severe reactions, including dehydration, allergic responses, and kidney issues. Patients might delay seeking medical help, assuming their treatment is working, thus losing valuable time and risking progression of their health problems.